GlassScriptPhysician profile
Mansi D Talati
NPI 1164712147
$876.00
in general payments reported to CMS, 2019-2025
19 companies · $23.99 in 2025
The $23.99 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $58.69 · 2021: $182 · 2022: $322 · 2023: $67.90 · 2024: $29.91 · 2025: $23.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $121.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $185.53 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $112.98 | 2019-2022 | |
| Alcon Vision LLC | $69.01 | 2022-2024 | Clareon |
| Allergan, INC. | $67.38 | 2019-2022 | |
| Abb Con-Cise Optical Group LLC | $61.58 | 2021 | |
| Sun Pharmaceutical Industries INC. | $60.90 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $37.97 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $32.84 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $32.49 | 2022 | |
| Sight Sciences, INC. | $31.26 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $28.90 | 2019-2020 | |
| Abbvie INC. | $23.99 | 2025 | |
| Apellis Pharmaceuticals, INC. | $23.83 | 2022 | |
| Rayner Intraocular Lenses Limited | $19.98 | 2022 | |
| Oyster Point Pharma, INC. | $19.58 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $19.45 | 2019 | |
| Shire North American Group INC | $17.77 | 2019 | |
| Dompe US, INC. | $16.56 | 2022 | |
| Akorn, INC. | $14.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mansi Talati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.